Clinical Trial Update: SHR-A1811 and THPy in First or Second Line for HER2 Positive Advanced Breast Cancer Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SHR-A1811 and THPy as first- or second-line treatment for HER2-positive advanced breast cancer with brain metastases; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SHR-A1811
• THPy

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING